Compare Aspen Aerogels Inc (ASPN) vs Levi Strauss & Co. (LEVI) Price & Performance

ASPN trades at $5.16, down 1.53% on the day, with a bearish technical signal despite oversold RSI readings. The company reported a Q1 2026 loss of $0.28 per share, missing estimates, but revenue beat expectations. Recent news includes a 2025 Supplier of the Year award from General Motors and the staged restart of its East Providence facility. Financials show significant net losses but improving cash flow trends into 2026.

Outlook remains challenging with persistent losses and negative margins, though analyst consensus is strongly bullish (83% buy ratings). Key risks include execution on facility restarts and EV demand volatility. The stock offers high-risk growth potential if operational improvements and electrification trends accelerate profitability.

Levi Strauss (LEVI) trades at $24.31, up 2.02% today, showing strong fundamental performance with consistent earnings beats and robust profitability metrics. The company recently raised its dividend and full-year guidance following Q2 2026 results, demonstrating confidence in its digital strategy and direct-to-consumer growth. Technical indicators show mixed signals with bearish overall momentum but strong support at $23. Analyst consensus remains overwhelmingly bullish with an 83% buy rating and $28 price target, representing 15% upside potential.

LEVI presents a compelling investment case with strong fundamentals, consistent earnings outperformance, and positive business momentum. Key opportunities include the successful digital transformation, expanding direct-to-consumer sales, and dividend growth. Risks include tariff pressures, foreign exchange volatility, and competitive retail landscape. The stock offers attractive valuation with 15% upside to consensus target, supported by strong cash flow generation and improving balance sheet metrics.